Studieoverzicht
BOOG nr.: |
Status: ( Closed )
|
Indication: ( View all )
|
Subindication: |
Menopausal status: |
2017-02 PERIDENO | Closed | Adjuvant | HER2-, any HR | Postmenopausal | ||||||||||||||
2014-05 INFLAME | Closed | Data registration | Not applicable | Not applicable | ||||||||||||||
2014-01 MONALEESA-2 | Closed | Advanced/metastatic | HER2- HR+ | Postmenopausal | ||||||||||||||
2013-07 mastectomie | Closed | Locoregional | Not applicable | Not applicable | ||||||||||||||
2013-06 Biomarker Study Everolimus | Closed | Advanced/metastatic | HER2- HR+ | Postmenopausal | ||||||||||||||
2013-03 PERNETTA | Closed | Advanced/metastatic | HER2+, any HR | Both pre- and postmenopausal | ||||||||||||||
2012-01 BALLET | Closed | Advanced/metastatic | HER2- HR+ | Postmenopausal | ||||||||||||||
2010-05 SUBMIT | Closed | Advanced/metastatic | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2010-03 RAPCHEM | Closed | Locoregional | Not applicable | Not applicable | ||||||||||||||
2010-02 STOP&GO | Closed | Advanced/metastatic | HER2-, any HR | Both pre- and postmenopausal | ||||||||||||||
2010-01 NEO-ZOTAC | Closed | Neoadjuvant | HER2-, any HR | Both pre- and postmenopausal | ||||||||||||||
2009-05 BOLERO 2 | Closed | Advanced/metastatic | HER2- HR+ | Postmenopausal | ||||||||||||||
2009-04 Male BC retrospectief | Closed | Data registration | Not applicable | Not applicable | ||||||||||||||
2009-02 SNARB | Closed | Locoregional | Not applicable | Not applicable | ||||||||||||||
2008-03 HAT | Closed | Advanced/metastatic | HER2+, any HR | Both pre- and postmenopausal | ||||||||||||||
2008-02 A6181099 | Closed | Advanced/metastatic | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2008-01 2-2-6 G-CSF | Closed | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2007-02 INTENS | Closed | Neoadjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2007-01 ALTTO | Closed | Adjuvant | HER2+, any HR | Both pre- and postmenopausal | ||||||||||||||
2006-07 MIRROR | Closed | Not applicable | Not applicable | Not applicable | ||||||||||||||
2006-06 ATX | Closed | Advanced/metastatic | HER2-, any HR | Both pre- and postmenopausal | ||||||||||||||
2006-04a TEAM IIa | Closed | Neoadjuvant | Any HER2, HR+ | Postmenopausal | ||||||||||||||
2006-02 OMEGA | Closed | Advanced/metastatic | Any HER2, any HR | Postmenopausal | ||||||||||||||
2006-01 DATA | Closed | Adjuvant | Any HER2, HR+ | Postmenopausal | ||||||||||||||
2004-02 TBP | Closed | Advanced/metastatic | HER2+, any HR | Both pre- and postmenopausal | ||||||||||||||
2003-02 Calor | Closed | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2002-04 HERA | Closed | Adjuvant | HER2+, any HR | Both pre- and postmenopausal | ||||||||||||||
2002-02 Hertax | Closed | Advanced/metastatic | HER2+, any HR | Both pre- and postmenopausal | ||||||||||||||
2001-02 AMAROS | Closed | Locoregional | Not applicable | Not applicable | ||||||||||||||
2001-01 TEAM | Closed | Adjuvant | Any HER2, HR+ | Postmenopausal |